| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-05 |